YMYusuke Minato

Yusuke Minato

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yusuke Minato has a total of 187 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Total Synthesis of Antrimycins A and D

    by Yoko Yasuno, Akito Nishimura, Yusaku Tamura, Ibuki Fujiwara, Atsushi Nakayama, Motoko Shinohara, Yusuke Minato, Masayoshi Arai, Tetsuro Shinada

    Antrimycins A and D were isolated from Streptomyces bacteria through a screening program for natural products with anti-Mycobacterium tuberculosis activity. These compounds belong to a class of heptapeptide natural products containing four non-proteinogenic amino acids, α-(hydroxymethyl)serine, (2S,3S)-α,β-diaminobutyric acid, dehydropiperazic acid, and E-dehydroisoleucine (E-Δ-Ile). These natural products have received significant attention as drug leads to develop structurally unique antibacterial agents against M. tuberculosis. However, no total synthesis has been reported since their isolation in 1981 owing to their characteristic structural features. Herein, we report the first total synthesis of antrimycins A and D. The total synthesis features the use of an (α-phosphono)-N-Cbz-glycine ester as a synthetic equivalent of E-Δ-Ile, enabling its stereoselective construction and incorporation into the peptide chain.

  • Open Access

    Integrated analysis of transposon insertion sequencing and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis

    by Kotaro Sawai, Marie Ikai, Motoko Shinohara, Yukiko Nishiuchi, So Fujiyoshi, Yohei Doi, Tomotada Iwamoto, Kentaro Arikawa, Fumito Maruyama, Yusuke Minato

    Pulmonary disease caused by non-tuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis , MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of Mycobacterium avium complex pulmonary disease patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing, and their gene essentiality profiles were compared to those of a previously studied sequence cluster 3 (SC3) lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH.

  • Matching-adjusted comparison of the effectiveness and safety of Ensitrelvir versus Remdesivir for high-risk, hospitalized patients with non-severe COVID-19 in Japan

    by Yoshikazu Mutoh, Toshiyuki Yamaguchi, Koki Sakurai, Yusuke Minato, Tomohiro Izumisawa, Tomoyoshi Kaneko, Takumi Umemura, Fumika Mizutani, Kazuaki Soejima, Satoshi Hagimoto, et al.

  • Open Access

    Identification of novel antimicrobial drug combinations with synergistic activity against Mycobacterium abscessus

    by Yui Kitagawa, Motoko Shinohara, Kayo Kumadaki, Shun Ito, Toshiharu Sasaki, Yohei Doi, Yusuke Minato

    Mycobacterium abscessus (Mab), classified as a rapid-growing mycobacterium, is naturally resistant to many antimicrobial drugs. Mab infections are typically treated with multidrug therapy, given low efficacy and risk of resistance development with monotherapy. Utilizing effective combinations of antimicrobial drugs with synergistic activity from the early stages of treatment may improve treatment success rates. We conducted a literature search of PubMed to identify studies published between 1992 and 2024 that assessed in vitro antimicrobial drug interactions in Mab. In addition, we evaluated in vitro drug interactions of 15 antimicrobial drugs that are clinically used in Japan. We utilized the diagonal measurement of n-way drug interactions (DiaMOND), a recently developed method to efficiently assess antimicrobial drug interactions. We experimentally identified 17 novel synergistic antimicrobial drug combinations against the standard Mab strain ATCC 19977. However, according to our literature review, only some synergistic interactions were conserved across different Mab strains. Combining a literature review and an in vitro assay, this study presents the most updated landscape of the activity of antimicrobial combinations against Mab.

  • Open Access

    Transposon insertion sequencing identifies genetic determinants of intrinsic rifamycin resistance in Mycobacterium abscessus

    by Kotaro Sawai, Hidetada Hirakawa, Tatehiko Mima, Yuta Morishige, Yasuhiro Maeda, Motoko Shinohara, Satoshi Mitarai, Yohei Doi, Yusuke Minato

    Mycobacterium abscessus exhibits intrinsic resistance to many antimicrobial agents, including rifampicin, a frontline anti-tuberculosis drug, severely limiting treatment options. Here, we used transposon insertion sequencing (Tn-Seq) to perform a genomewide screen to identify genes required for intrinsic rifampicin resistance in M. abscessus . We uncovered candidate genes that confer intrinsic resistance to the rifamycin-class antibiotics, rifampicin and rifabutin. The genes we identified included previously reported genes such as arr , helR , and MAB_2807 . By comparing our results with the rifampicin intrinsic resistance gene in Mycobacterium tuberculosis , we found that the mechanisms underlying rifampicin intrinsic resistance were distinct between the two species. The contribution of seven representative candidate genes to rifampicin resistance was confirmed by characterizing targeted gene deletion or transposon insertion mutants. Among these determinants, MAB_2807 was identified as a major efflux-based contributor to rifamycin resistance, and its disruption increased intracellular rifampicin accumulation. In addition to known resistance determinants, Tn-Seq revealed contributions from many genes involved in cell envelope processes to rifamycin resistance. Guided by this genetic signature, we evaluated the combined effects of cell wall-targeting antimicrobial agents with rifamycins. We found that rifamycins displayed selective synergistic interactions with specific β-lactam antibiotics. Interestingly, we found that rifamycin exposure altered cell envelope ultrastructure and increased the accumulation of the peptidoglycan precursor UDP-N-acetylglucosamine, suggesting that rifampicin perturbs envelope-associated metabolic homeostasis. These findings highlight rifamycin-induced vulnerable cellular processes that may inform rational combination strategies.

  • Open Access

    Establishment of an in vivo -based assay using a silkworm infection model for phenotypic evaluation of antimicrobial drug combinations against Mycobacterium abscessus

    by Akiho Yagi, Motoko Shinohara, Yusuke Minato, Ryuji Uchida

    Mycobacterium abscessus exhibits high intrinsic drug resistance, requiring combination therapy. We developed a silkworm ( Bombyx mori ) infection model as a whole-organism, in vivo -based platform for quantitative, outcome-based evaluations of antimicrobial combinations. The system, examined using clarithromycin-amikacin and imipenem-cefoxitin combinations, showed interaction profiles that were qualitatively consistent with those observed in vitro . This rapid, reproducible, and ethical assay enables reliable phenotypic assessments of synergistic or antagonistic effects and may facilitate the evaluation and prioritization of antimicrobial combination regimens in preclinical studies.

  • Open Access

    Diagnostic utility of quantitative interferon-gamma release assays in elderly patients with tuberculosis

    by Yoshikazu Mutoh, Yusuke Minato, Yuya Kawamoto, Shogo Hanai, Takumi Umemura, Hiroko Suzuki, Yuta Nishina, Kaho Hiramitsu, Seiya Ichihara, Satoshi Hagimoto, et al.

    Evidence regarding the diagnostic value of quantitative interferon-gamma release assay (IGRA) results in elderly populations is limited, and large-scale data for QuantiFERON-TB Gold Plus (QFT-Plus) are scarce. We evaluated QFT-Plus and T-SPOT.TB (T-SPOT) for distinguishing active tuberculosis (ATB) from latent infection (LTBI) in elderly individuals in Japan, a super-aged country. We conducted a retrospective, cross-sectional diagnostic accuracy study of patients ≥65 years who underwent IGRA testing between 2015 and 2024 at two hospitals: a tuberculosis referral center (QFT-Plus and T-SPOT) and a tertiary hospital (T-SPOT only). ATB was defined as microbiologically confirmed TB. Quantitative IGRA values were compared between ATB and LTBI in all patients and in IGRA-positive subsets. Receiver operating characteristic (ROC) curves assessed discriminatory performance. Among 10,745 elderly patients (ATB: n = 310; LTBI: n = 1,158), values showed substantial overlap. For T-SPOT, the area under the curves (AUCs) improved at Tosei General Hospital (TGH) (ESAT-6: 0.679, CFP-10: 0.670) in IGRA-positive cases. In contrast, all-patient AUCs at Fujita Health University Hospital (FHUH) were low (ESAT-6: 0.367, CFP-10: 0.362), demonstrating an inverse association, though they improved (ESAT-6: 0.607 and CFP-10: 0.554) in IGRA-positive cases. For QFT-Plus, all-patient AUCs were low (TB1 antigen: 0.462, TB2 antigen: 0.470), but improved in the IGRA-positive cohort (TB1 antigen: 0.630, TB2 antigen: 0.645). The optimal quantitative cutoffs in IGRA-positive cases provided modest diagnostic accuracy. In elderly individuals, quantitative IGRA values alone have limited ability to distinguish ATB from LTBI, but QFT-Plus and T-SPOT show modest improvement in IGRA-positive cases. Although not suitable as a stand-alone diagnostic, quantitative IGRA may assist risk stratification and decision-making in selected scenarios. IMPORTANCE: Tuberculosis remains a major health concern in aging societies, such as Japan, where most patients are elderly adults with impaired immune function. Interferon-gamma release assays (IGRA) are widely used for detecting infection, but the role of their quantitative values in differentiating active tuberculosis from latent tuberculosis infection has been uncertain. Our study is the first to evaluate the quantitative performance of the latest QuantiFERON-TB Gold Plus and T-SPOT.TB specifically in elderly patients, across both a tuberculosis referral hospital and a university hospital. Although absolute separation between active and latent disease was not achieved, we found that, in test-positive individuals, active cases tended to yield higher values, particularly with T-SPOT.TB. This indicates that quantitative information, when interpreted within the clinical context, can assist physicians in assessing risk and guiding further diagnostic steps, offering practical value for improving decision-making in the care of vulnerable elderly patients.

  • Open Access

    Nosocomial Mycobacterium lentiflavum colonization and infection cluster at a Japanese tertiary care center: report of an outbreak/pseudo-outbreak investigation

    by Shushi Okuno, Junko Makino, Yoshihiro Nanjo, Yoshiko Takayama, Marie Ikai, Kotaro Sawai, Yusuke Minato, Hitoshi Honda

    Objective: Mycobacterium lentiflavum is a rare, non-tuberculous mycobacterium (NTM) which is implicated in some cases of active, pulmonary non-tuberculous mycobacterial disease. The outbreak of NTM in nosocomial settings occasionally occurs and outbreak investigation with implementation of concurrent countermeasure is essential. Design: Outbreak investigation. Setting: A tertiary care medical center. Patients and participants: Hospitalized patients during the outbreak period. Results: In April 2024, a cluster of patients with Mycobacterium lentiflavum –positive sputum cultures, presumed to be due to nosocomial transmission, was identified at the study center. A retrospective review of cases dating back to February 2023 revealed 27 patients with M. lentiflavum infection whose isolates had initially not been speciated. According to the American Thoracic Society (ATS) criteria for diagnosing pulmonary non-tuberculous mycobacterial (NTM) disease, two of these patients met the criteria for active disease. Multi-locus sequence typing of 12 isolates demonstrated 100% clonality, indicating a common source. A concurrent outbreak investigation identified contaminated faucet aerators in hospital wards as the likely source of transmission. All faucet aerators and caps were manually cleaned and disinfected using liquid sodium hypochlorite, after which no further cases were detected. Conclusion: The present study described a nosocomial cluster of M. lentiflavum colonization and infections at a tertiary care center, with contaminated faucet aerators identified as the likely source. Prompt identification of such NTM clusters in healthcare settings is essential to initiate timely treatment and prevent further transmission.

  • Open Access

    Functional genomics reveals strain-specific genetic requirements conferring hypoxic growth in Mycobacterium intracellulare

    by Yoshitaka Tateishi, Yuriko Ozeki, Akihito Nishiyama, Yuta Morishige, Yusuke Minato, Anthony David Baughn, Sohkichi Matsumoto

    Mycobacterium intracellulare is a major etiological agent of the recently expanding Mycobacterium avium–intracellulare complex pulmonary disease (MAC-PD). Therapeutic regimens that include a combination of macrolides and antituberculous drugs have been implemented with limited success. To identify novel targets for drug development that accommodate the genomic diversity of M. avium–intracellulare , we subjected eight clinical MAC-PD isolates and the type strain ATCC13950 to genome-wide profiling to comprehensively identify universally essential functions by transposon sequencing (TnSeq). Among these strains, we identified 131 shared essential or growth-defect-associated genes by TnSeq. Unlike the type strain, the clinical strains showed increased requirements for genes involved in gluconeogenesis and the type VII secretion system under standard growth conditions, the same genes required for hypoxic pellicle-type biofilm formation in ATCC13950. Consistent with the central role of hypoxia in the evolution of M. intracellulare , the clinical MAC-PD strains showed more rapid adaptation to hypoxic growth than the type strain. Importantly, the increased requirements of hypoxic fitness genes were confirmed in a mouse lung infection model. These findings confirm the concordant genetic requirements under hypoxic conditions in vitro and hypoxia-related conditions in vivo and highlight the importance of using clinical strains and host-relevant growth conditions to identify high-value targets for drug development.


  • Open Access

    Integrated analysis of Tn-Seq and pangenome reveals core and lineage-specific essential genes in Mycobacterium avium subsp. hominissuis

    by Kotaro Sawai, Marie Ikai, Motoko Shinohara, Yukiko Nishiuchi, So Fujiyoshi, Yohei Doi, Tomotada Iwamoto, Kentaro Arikawa, Fumito Maruyama, Yusuke Minato

    Pulmonary disease caused by nontuberculous mycobacteria (NTM-PD) is an emerging global health concern. Among NTM, Mycobacterium avium subsp. hominissuis (MAH) is the major causative agent of NTM-PD. Similar to Mycobacterium tuberculosis ( Mtb ), MAH exhibits lineage-specific geographical distributions and host adaptations. Here, we characterized three MAH strains from the residential bathrooms of MAH-PD patients in Japan. A genetic population clustering analysis revealed that the three strains belong to the East Asia (EA) lineages that are predominant in Japan and Korea. Pan-genome analysis using the publicly available complete genome sequences of MAH and the newly sequenced MAH strains identified 3,313 core genes that are conserved among distinct MAH lineages. Identification of essential genes in the three strains was conducted using transposon insertion sequencing (Tn-Seq), and their gene essentiality profiles were compared to those of a previously studied SC3 lineage strain, MAC109. Despite their genetic diversity, nearly all essential genes were derived from the core gene set. In addition, we identified a set of common essential genes for the EA and SC3 lineages, as well as lineage-specific essential genes. Our results highlight the evolutionary and clinical importance of lineage-specific adaptations in MAH. Importance: By integrating transposon insertion sequencing with pan-genome analysis, we provide the first systematic comparison of essential genes across multiple Mycobacterium avium subsp. hominissuis (MAH) strains. Although MAH strains exhibit remarkable genetic diversity, we found that MAH essential genes are primarily confined to the core genome of MAH. This essential plasticity highlights the evolutionary strategies that underpin MAH survival across diverse environments and patient populations. Recognizing this interplay provides a foundation for identifying robust drug targets and developing lineage-informed therapies for MAH infection.